vs
ICON PLC（ICLR）与Inotiv, Inc.（NOTV）财务数据对比。点击上方公司名可切换其他公司
ICON PLC的季度营收约是Inotiv, Inc.的16.9倍（$2.0B vs $120.9M）。ICON PLC净利率更高（0.1% vs -23.5%，领先23.6%）。Inotiv, Inc.同比增速更快（0.8% vs 0.6%）。ICON PLC自由现金流更多（$333.9M vs $-10.6M）。过去两年Inotiv, Inc.的营收复合增速更高（0.8% vs 0.6%）
ICON plc是总部位于爱尔兰的跨国医疗智能与临床研究服务机构，专注为全球医药健康领域客户提供专业研究及情报支持，截至2025年2月，已在全球55个国家布局业务，员工规模约4.19万人。
Inotiv公司是一家注册于美国印第安纳州的合同研究组织，总部位于该州拉斐特市。公司设有两大核心业务板块：发现与安全评估业务（DSA）以及研究模型与服务业务（RMS），可为小分子候选药物、生物治疗产品及生物医疗设备提供安全评估、分析、代谢研究、CMC及法规咨询等药物开发与环境科学相关服务。
ICLR vs NOTV — 直观对比
营收规模更大
ICLR
是对方的16.9倍
$120.9M
营收增速更快
NOTV
高出0.2%
0.6%
净利率更高
ICLR
高出23.6%
-23.5%
自由现金流更多
ICLR
多$344.5M
$-10.6M
两年增速更快
NOTV
近两年复合增速
0.6%
损益表 — Q3 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $2.0B | $120.9M |
| 净利润 | $2.4M | $-28.4M |
| 毛利率 | — | — |
| 营业利润率 | 4.2% | -13.5% |
| 净利率 | 0.1% | -23.5% |
| 营收同比 | 0.6% | 0.8% |
| 净利润同比 | -98.8% | -2.7% |
| 每股收益（稀释后） | $0.03 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICLRNOTV
| Q4 25 | — | $120.9M | ||
| Q3 25 | $2.0B | $138.1M | ||
| Q2 25 | $2.0B | $130.7M | ||
| Q1 25 | $2.0B | $124.3M | ||
| Q4 24 | — | $119.9M | ||
| Q3 24 | $2.0B | $130.4M | ||
| Q2 24 | $2.1B | $105.8M | ||
| Q1 24 | $2.1B | $119.0M |
净利润ICLRNOTV
| Q4 25 | — | $-28.4M | ||
| Q3 25 | $2.4M | $-8.6M | ||
| Q2 25 | $183.0M | $-17.6M | ||
| Q1 25 | $154.2M | $-14.9M | ||
| Q4 24 | — | $-27.6M | ||
| Q3 24 | $197.1M | $-18.9M | ||
| Q2 24 | $146.9M | $-26.1M | ||
| Q1 24 | $187.4M | $-48.1M |
营业利润率ICLRNOTV
| Q4 25 | — | -13.5% | ||
| Q3 25 | 4.2% | -4.9% | ||
| Q2 25 | 10.4% | -4.3% | ||
| Q1 25 | 11.0% | -2.4% | ||
| Q4 24 | — | -12.9% | ||
| Q3 24 | 14.1% | -10.1% | ||
| Q2 24 | 10.8% | -19.6% | ||
| Q1 24 | 13.7% | -36.2% |
净利率ICLRNOTV
| Q4 25 | — | -23.5% | ||
| Q3 25 | 0.1% | -6.2% | ||
| Q2 25 | 9.1% | -13.5% | ||
| Q1 25 | 7.7% | -12.0% | ||
| Q4 24 | — | -23.0% | ||
| Q3 24 | 9.7% | -14.5% | ||
| Q2 24 | 6.9% | -24.7% | ||
| Q1 24 | 9.0% | -40.4% |
每股收益（稀释后）ICLRNOTV
| Q4 25 | — | $-0.83 | ||
| Q3 25 | $0.03 | $-0.14 | ||
| Q2 25 | $2.30 | $-0.51 | ||
| Q1 25 | $1.90 | $-0.44 | ||
| Q4 24 | — | $-1.02 | ||
| Q3 24 | $2.36 | $-0.73 | ||
| Q2 24 | $1.76 | $-1.00 | ||
| Q1 24 | $2.25 | $-1.86 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $468.9M | $12.7M |
| 总债务越低越好 | — | $405.8M |
| 股东权益账面价值 | $9.3B | $109.0M |
| 总资产 | $16.5B | $734.3M |
| 负债/权益比越低杠杆越低 | — | 3.72× |
8季度趋势，按日历期对齐
现金及短期投资ICLRNOTV
| Q4 25 | — | $12.7M | ||
| Q3 25 | $468.9M | $21.7M | ||
| Q2 25 | $390.4M | $6.2M | ||
| Q1 25 | $526.7M | $19.3M | ||
| Q4 24 | — | $38.0M | ||
| Q3 24 | $695.5M | $21.4M | ||
| Q2 24 | $506.6M | $14.4M | ||
| Q1 24 | $396.1M | $32.7M |
总债务ICLRNOTV
| Q4 25 | — | $405.8M | ||
| Q3 25 | — | $402.1M | ||
| Q2 25 | — | $396.5M | ||
| Q1 25 | — | $399.5M | ||
| Q4 24 | — | $396.0M | ||
| Q3 24 | — | $393.3M | ||
| Q2 24 | — | $382.4M | ||
| Q1 24 | — | $380.6M |
股东权益ICLRNOTV
| Q4 25 | — | $109.0M | ||
| Q3 25 | $9.3B | $136.0M | ||
| Q2 25 | $9.6B | $143.8M | ||
| Q1 25 | $9.5B | $157.7M | ||
| Q4 24 | — | $169.8M | ||
| Q3 24 | $9.8B | $170.5M | ||
| Q2 24 | $9.6B | $182.1M | ||
| Q1 24 | $9.4B | $207.2M |
总资产ICLRNOTV
| Q4 25 | — | $734.3M | ||
| Q3 25 | $16.5B | $771.1M | ||
| Q2 25 | $16.6B | $759.7M | ||
| Q1 25 | $16.7B | $766.0M | ||
| Q4 24 | — | $772.9M | ||
| Q3 24 | $17.2B | $781.4M | ||
| Q2 24 | $17.0B | $774.6M | ||
| Q1 24 | $17.0B | $815.4M |
负债/权益比ICLRNOTV
| Q4 25 | — | 3.72× | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 2.76× | ||
| Q1 25 | — | 2.53× | ||
| Q4 24 | — | 2.33× | ||
| Q3 24 | — | 2.31× | ||
| Q2 24 | — | 2.10× | ||
| Q1 24 | — | 1.84× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $387.6M | $-5.4M |
| 自由现金流经营现金流 - 资本支出 | $333.9M | $-10.6M |
| 自由现金流率自由现金流/营收 | 16.3% | -8.8% |
| 资本支出强度资本支出/营收 | 2.6% | 4.3% |
| 现金转化率经营现金流/净利润 | 164.59× | — |
| 过去12个月自由现金流最近4个季度 | $1.0B | $-28.7M |
8季度趋势，按日历期对齐
经营现金流ICLRNOTV
| Q4 25 | — | $-5.4M | ||
| Q3 25 | $387.6M | $14.3M | ||
| Q2 25 | $146.2M | $-7.4M | ||
| Q1 25 | $268.2M | $-12.8M | ||
| Q4 24 | — | $-4.5M | ||
| Q3 24 | $402.7M | $-2.4M | ||
| Q2 24 | $218.6M | $-14.8M | ||
| Q1 24 | $327.1M | $16.9M |
自由现金流ICLRNOTV
| Q4 25 | — | $-10.6M | ||
| Q3 25 | $333.9M | $11.6M | ||
| Q2 25 | $113.9M | $-11.5M | ||
| Q1 25 | $239.3M | $-18.3M | ||
| Q4 24 | — | $-9.0M | ||
| Q3 24 | $359.3M | $-7.7M | ||
| Q2 24 | $182.3M | $-19.2M | ||
| Q1 24 | $299.9M | $9.9M |
自由现金流率ICLRNOTV
| Q4 25 | — | -8.8% | ||
| Q3 25 | 16.3% | 8.4% | ||
| Q2 25 | 5.6% | -8.8% | ||
| Q1 25 | 12.0% | -14.7% | ||
| Q4 24 | — | -7.5% | ||
| Q3 24 | 17.7% | -5.9% | ||
| Q2 24 | 8.6% | -18.2% | ||
| Q1 24 | 14.3% | 8.3% |
资本支出强度ICLRNOTV
| Q4 25 | — | 4.3% | ||
| Q3 25 | 2.6% | 1.9% | ||
| Q2 25 | 1.6% | 3.1% | ||
| Q1 25 | 1.4% | 4.4% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | 2.1% | 4.1% | ||
| Q2 24 | 1.7% | 4.2% | ||
| Q1 24 | 1.3% | 5.9% |
现金转化率ICLRNOTV
| Q4 25 | — | — | ||
| Q3 25 | 164.59× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 1.74× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.04× | — | ||
| Q2 24 | 1.49× | — | ||
| Q1 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICLR
| Other Customers | $681.3M | 33% |
| Clients1125 | $549.4M | 27% |
| Clients15 | $503.3M | 25% |
| Clients610 | $308.8M | 15% |
NOTV
| Research Models And Services Segment | $72.9M | 60% |
| Discovery And Safety Assessment Segment | $48.0M | 40% |
